Overview
A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of anxiety disorders, and also for the short-term management of insomnia but has largely been superseded by the benzodiazepines. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603) Meprobamate is a controlled substance in the U.S.
Indication
For the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.
Associated Conditions
- Anxiety Disorders
- Pain
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Taro Pharmaceuticals U.S.A., Inc. | 51672-4147 | ORAL | 200 mg in 1 1 | 1/15/2019 | |
| Cipla USA Inc. | 69097-974 | ORAL | 200 mg in 1 1 | 6/19/2021 | |
| Dr.Reddy's Laboratories Limited | 55111-640 | ORAL | 200 mg in 1 1 | 9/9/2009 | |
| Dr.Reddy's Laboratories Limited | 55111-641 | ORAL | 400 mg in 1 1 | 9/9/2009 | |
| Taro Pharmaceuticals U.S.A., Inc. | 51672-4148 | ORAL | 400 mg in 1 1 | 1/15/2019 | |
| Alembic Pharmaceuticals Inc. | 62332-020 | ORAL | 400 mg in 1 1 | 10/1/2021 | |
| Taro Pharmaceutical Industries Ltd. | 52549-4147 | ORAL | 200 mg in 1 1 | 7/19/2011 | |
| Cipla USA Inc. | 69097-975 | ORAL | 400 mg in 1 1 | 6/19/2021 | |
| Alembic Pharmaceuticals Inc. | 62332-019 | ORAL | 200 mg in 1 1 | 10/1/2021 | |
| Alembic Pharmaceuticals Limited | 46708-019 | ORAL | 200 mg in 1 1 | 1/10/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| APO MEPROBAMATE TAB 400MG | 00337943 | Tablet - Oral | 400 MG / TAB | 12/31/1975 | |
| NOVO-MEPRO 400MG | novopharm limited | 00021547 | Tablet - Oral | 400 MG | 12/31/1967 |
| MEPROBAMATE TAB 400MG | PRO DOC LIMITEE | 00156620 | Tablet - Oral | 400 MG / TAB | 12/31/1959 |
| MEPROBAMATE TAB 400MG | 00431095 | Tablet - Oral | 400 MG / TAB | 12/31/1978 | |
| 282 MEP TAB | merck frosst canada & cie, merck frosst canada & co. | 00108316 | Tablet - Oral | 200 MG | 12/31/1959 |
| NOVO-MEPRO 200MG | novopharm limited | 00021539 | Tablet - Oral | 200 MG | 12/31/1967 |
| MEDITRAN 400MG | medic laboratory ltée | 00134368 | Tablet - Oral | 400 MG | 12/31/1959 |
| EQUAGESIC TABLETS | wyeth-ayerst canada inc. | 02041804 | Tablet - Oral | 200 MG / TAB | 12/31/1995 |
| EQUANIL TABLETS 400MG | wyeth-ayerst canada inc. | 02041812 | Tablet - Oral | 400 MG / TAB | 12/31/1994 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.